New oral medication shows promise for controlling rare swelling disorder

NCT ID NCT05505916

Ongoing Disease control Sponsor: KalVista Pharmaceuticals, Ltd. Source: ClinicalTrials.gov ↗

Summary

This study is testing the long-term safety of an oral medication called KVD900 for treating sudden swelling attacks in people with hereditary angioedema. The trial includes 145 patients aged 12 and older who have type I or II hereditary angioedema and have experienced at least two attacks in the previous three months. Participants take KVD900 as needed when attacks occur, while researchers monitor for side effects and how well the medication relieves symptoms.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

KalVista Investgative Site

Layton, Utah, 84041, United States
KalVista Investgative Site

Tokyo, 142-8666, Japan
KalVista Investigative Site

Scottsdale, Arizona, 85251, United States
KalVista Investigative Site

Little Rock, Arkansas, 72205, United States
KalVista Investigative Site

San Diego, California, 92122, United States
KalVista Investigative Site

San Diego, California, 92123, United States
KalVista Investigative Site

Santa Monica, California, 90404, United States
KalVista Investigative Site

Centennial, Colorado, 80112, United States
KalVista Investigative Site

Colorado Springs, Colorado, 80907, United States
KalVista Investigative Site

Evansville, Indiana, 47715, United States
KalVista Investigative Site

Overland Park, Kansas, 66211, United States
KalVista Investigative Site

Louisville, Kentucky, 40215, United States
KalVista Investigative Site

Chevy Chase, Maryland, 20815, United States
KalVista Investigative Site

Plymouth, Minnesota, 55446, United States
KalVista Investigative Site

St Louis, Missouri, 63141, United States
KalVista Investigative Site

Charlotte, North Carolina, 28277, United States
KalVista Investigative Site

Cincinnati, Ohio, 45236, United States
KalVista Investigative Site

Toledo, Ohio, 43617, United States
KalVista Investigative Site

Hershey, Pennsylvania, 17033, United States
KalVista Investigative Site

Dallas, Texas, 75231, United States
KalVista Investigative Site

Spokane, Washington, 99204, United States
KalVista Investigative Site

Campbelltown, 2560, Australia
KalVista Investigative Site

Wein, 1090, Austria
KalVista Investigative Site

Sofia, 1431, Bulgaria
KalVista Investigative Site

Montreal, H2W 1R7, Canada
KalVista Investigative Site

Grenoble, 38043, France
KalVista Investigative Site

Lille, 59037, France
KalVista Investigative Site

Paris, 75012, France
KalVista Investigative Site

Berlin, 12203, Germany
KalVista Investigative Site

Frankfurt, 60590, Germany
KalVista Investigative Site

Mainz, 55131, Germany
KalVista Investigative Site

Mörfelden-Walldorf, 64546, Germany
KalVista Investigative Site

Athens, 11521, Greece
KalVista Investigative Site

Athens, 11527, Greece
KalVista Investigative Site

Budapest, 1088, Hungary
KalVista Investigative Site

Haifa, 31048, Israel
KalVista Investigative Site

Petach Tikvah, 4920235, Israel
KalVista Investigative Site

Ramat Gan, 52621, Israel
KalVista Investigative Site

Tel Aviv, 64239, Israel
KalVista Investigative Site

Padua, 35128, Italy
KalVista Investigative Site

Palermo, 90146, Italy
KalVista Investigative Site

Roma, 00133, Italy
KalVista Investigative Site

San Donato Milanese, 20097, Italy
KalVista Investigative Site

Sapporo, Hokkaido, 002-8072, Japan
KalVista Investigative Site

Chiba, 260-8677, Japan
KalVista Investigative Site

Hiroshima, 730-8518, Japan
KalVista Investigative Site

Kawagoe-shi, 350-8550, Japan
KalVista Investigative Site

Maebashi, 371-8511, Japan
KalVista Investigative Site

Soka-shi, 340-0041, Japan
KalVista Investigative Site

Takatsuki-shi, 569-8686, Japan
KalVista Investigative Site

Yokohama, 236-0004, Japan
KalVista Investigative Site

Amsterdam, 1105 AZ, Netherlands
KalVista Investigative Site

Auckland, 1023, New Zealand
KalVista Investigative Site

Skopje, 1000, North Macedonia
KalVista Investigative Site

Krakow, 31-503, Poland
KalVista Investigative Site

Lodz, 92-213, Poland
KalVista Investigative Site

Porto, 4200-319, Portugal
KalVista Investigative Site

Sângeorgiu de Mureş, 547530, Romania
KalVista Investigative Site

Riyadh, 11211, Saudi Arabia
KalVista Investigative Site

Martin, 036 59, Slovakia
KalVista Investigative Site

Barcelona, 08035, Spain
KalVista Investigative Site

Barcelona, 08907, Spain
KalVista Investigative Site

Madrid, 28046, Spain
KalVista Investigative Site

Birmingham, B9 5SS, United Kingdom
KalVista Investigative Site

Cambridge, CB2 0QQ, United Kingdom
KalVista Investigative Site

Cardiff, CF14 4XW, United Kingdom
KalVista Investigative Site

Frimley, GU16 7UJ, United Kingdom
KalVista Investigative Site

Leeds, LS9 7TF, United Kingdom
KalVista Investigative Site

London, E1 2ES, United Kingdom
KalVista Investigative Site

London, NW3 2QG, United Kingdom
Kalvista Investigative Site

Cape Town, 7700, South Africa

Conditions

Explore the condition pages connected to this study.

HEREDITARY ANGIOEDEMA